INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 192 filers reported holding INSMED INC in Q3 2021. The put-call ratio across all filers is 1.27 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $512 | +2227.3% | 24,304 | +1769.5% | 0.00% | – |
Q1 2023 | $22 | -100.0% | 1,300 | -86.0% | 0.00% | – |
Q3 2021 | $273,000 | -7.5% | 9,284 | -10.6% | 0.00% | – |
Q2 2021 | $295,000 | +30.0% | 10,384 | +55.3% | 0.00% | – |
Q1 2021 | $227,000 | +440.5% | 6,687 | +428.2% | 0.00% | – |
Q4 2020 | $42,000 | -95.5% | 1,266 | -95.6% | 0.00% | -100.0% |
Q3 2020 | $925,000 | +428.6% | 28,785 | +291.2% | 0.00% | – |
Q4 2019 | $175,000 | +573.1% | 7,359 | +620.8% | 0.00% | – |
Q2 2019 | $26,000 | +160.0% | 1,021 | +27.6% | 0.00% | – |
Q4 2018 | $10,000 | -85.5% | 800 | -84.8% | 0.00% | -100.0% |
Q4 2016 | $69,000 | -46.5% | 5,263 | -40.8% | 0.00% | -55.6% |
Q3 2016 | $129,000 | -60.1% | 8,891 | -72.9% | 0.01% | -59.1% |
Q2 2016 | $323,000 | +382.1% | 32,801 | +514.7% | 0.02% | +340.0% |
Q1 2016 | $67,000 | -85.6% | 5,336 | -79.2% | 0.01% | -86.1% |
Q4 2015 | $465,000 | +255.0% | 25,643 | +260.8% | 0.04% | +260.0% |
Q3 2015 | $131,000 | -55.4% | 7,107 | -49.8% | 0.01% | -70.6% |
Q1 2015 | $294,000 | +913.8% | 14,160 | +653.6% | 0.03% | +750.0% |
Q4 2014 | $29,000 | – | 1,879 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Palo Alto Investors LP | 5,889,491 | $100,415,822 | 8.32% |
Deep Track Capital, LP | 6,500,000 | $110,825,000 | 4.55% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 2,932,138 | $49,992,953 | 2.11% |
Endurant Capital Management LP | 230,006 | $3,921,602 | 2.01% |
Ikarian Capital, LLC | 485,000 | $8,269,250 | 1.88% |
MPM BioImpact LLC | 399,192 | $6,806,224 | 1.77% |
SECTORAL ASSET MANAGEMENT INC | 516,092 | $8,799,369 | 1.69% |
Novo Holdings A/S | 1,339,304 | $22,835,133 | 1.51% |
First Light Asset Management, LLC | 750,883 | $12,802,555 | 1.15% |
SILVERARC CAPITAL MANAGEMENT, LLC | 143,794 | $2,451,688 | 1.01% |